Wedbush Securities’s Aceragen Inc ACGN Stock Holding History

Wedbush Securities’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,490	Closed	-$45K	–	1037
2020 Q2	$45K	Buy	+1,490	New	+$46K	﹤0.01%	915
2020 Q1	–	Sell	-966	Closed	-$30K	–	1032
2019 Q4	$30K	Buy	+966	New	+$35.9K	﹤0.01%	977
2018 Q3	–	Sell	-128	Closed	-$23K	–	950
2018 Q2	$23K	Buy	+128	New	+$29.9K	﹤0.01%	861
2018 Q1	–	Sell	-686	Closed	-$197K	–	907
2017 Q4	$197K	Hold	686	–	–	0.02%	720
2017 Q3	$208K	Sell	686 -2	-0.3%	-$523	0.03%	692
2017 Q2	$161K	Buy	688 +20	+3%	+$5.23K	0.02%	738
2017 Q1	$224K	Sell	668 -162	-20%	-$39.1K	0.03%	639
2016 Q4	$169K	Buy	+830	New	+$198K	0.02%	688

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Wedbush Securities's ACGN Position: Q3 2020 in Review

Wedbush Securities sold out of Aceragen Inc (ACGN) in Q3 2020, closing a stake of 1,490 shares — an estimated $45K sold.

Wedbush Securities first reported a position in ACGN in Q4 2016 and held it in 8 quarters. The position peaked at $224K in Q1 2017. 40 funds tracked by Wall St. Rank hold ACGN as of Q3 2020.

Wedbush Securities reported no remaining Aceragen Inc position as of Q3 2020 after selling out during the quarter.
Wedbush Securities sold 1,490 Aceragen Inc shares in Q3 2020, an estimated $45K.
Wedbush Securities first reported a position in Aceragen Inc in Q4 2016 and held it in 8 quarters.
Wedbush Securities's Aceragen Inc position peaked at $224K in Q1 2017.
40 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2020.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.